Search results
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 18 hours agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 1 hour agoJPMorgan said early results suggest the drug candidate offers "on par" weight loss results for...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 9 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports
WHTC 1450 Holland· 6 days ago(Reuters) - Pfizer has agreed offer payment of up to $250 million to settle more than 10,000...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK
Morningstar· 9 hours agoBy Adriano Marchese Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 5 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga· 9 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 5 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...